Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Tumours × Irinotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 48 Unspecified Adult Solid Tumor, Protocol Specific 25 Neoplasms 25 Pancreatic Neoplasms 23 Colonic Neoplasms 22 Neoplasm Metastasis 20 Stomach Neoplasms 19 Rectal Neoplasms 19 Neuroblastoma 12 Lung Neoplasms 12 Esophageal Neoplasms 10 Small Cell Lung Carcinoma 9 Carcinoma, Non-Small-Cell Lung 9 Brain Neoplasms 9 Glioblastoma 8 Breast Neoplasms 8 Central Nervous System Neoplasms 7 Astrocytoma 7 Oligodendroglioma 6 Gliosarcoma 6 Glioma 6 Gallbladder Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Carcinoma, Hepatocellular 6 Bile Duct Neoplasms 6 Unspecified Childhood Solid Tumor, Protocol Specific 5 Solid Tumor 5 Liver Neoplasms 5 Triple Negative Breast Neoplasms 4 Solid Tumors 4

Interventions

adavosertib 4 Paclitaxel 3 olaparib 2 durvalumab 2 ceralasertib 2 Fluorouracil 2 Carboplatin 2 pembrolizumab 1 factor IX, factor VII, factor X, prothrombin drug combination 1 drug XX Z 1 danvatirsen 1 capivasertib 1 Rifampin 1 Pantoprazole 1 Omeprazole 1 Leucovorin 1 Itraconazole 1 Irinotecan 1 Injections 1 Gemcitabine 1 Doxorubicin 1 Cisplatin 1 AZD0156 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02588105 2022-09-19

AToM

AstraZeneca

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡